We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+9.91%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$1.1B
AUM Growth
+$73.5M
Cap. Flow
-$16.3M
Cap. Flow %
-1.48%
Top 10 Hldgs %
28.91%
Holding
248
New
4
Increased
56
Reduced
116
Closed
11

Top Buys

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$2.39M
2
ABBV icon
AbbVie
ABBV
+$1.05M
3
SYK icon
Stryker
SYK
+$910K
4
APD icon
Air Products & Chemicals
APD
+$856K
5
RLAY icon
Relay Therapeutics
RLAY
+$805K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.51M
2
MIDD icon
Middleby
MIDD
+$2.65M
3
MRSH
Marsh
MRSH
+$1.4M
4
AMZN icon
Amazon
AMZN
+$1.02M
5
AFL icon
Aflac
AFL
+$1M

Sector Composition

Rank Sector Weight
1 Technology 22.19%
2 Healthcare 16.25%
3 Financials 9.14%
4 Industrials 8.55%
5 Consumer Discretionary 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSCO icon
76
Cisco
CSCO
$479B
$3.18M 0.29%
80,704
-4,057
-5% -$177K
PFE icon
77
Pfizer
PFE
$153B
$3.12M 0.28%
89,656
-1,259
-1% -$44.1K
VIG icon
78
Vanguard Dividend Appreciation ETF
VIG
$114B
$3M 0.27%
23,322
-380
-2% -$47.8K
VEA icon
79
Vanguard FTSE Developed Markets ETF
VEA
$237B
$2.98M 0.27%
72,827
+1,030
+1% +$42.3K
DIS icon
80
Walt Disney
DIS
$181B
$2.97M 0.27%
23,963
-1,140
-5% -$142K
VEU icon
81
Vanguard FTSE All-World ex-US ETF
VEU
$70.2B
$2.88M 0.26%
57,163
-5,355
-9% -$272K
FDX icon
82
FedEx
FDX
$75.4B
$2.81M 0.25%
11,160
– –
VXF icon
83
Vanguard Extended Market ETF
VXF
$31.9B
$2.8M 0.25%
21,613
+502
+2% +$63.9K
MDLZ icon
84
Mondelez International
MDLZ
$79.9B
$2.68M 0.24%
46,726
+81
+0.2% +$4.51K
NVO
85
Novo Nordisk
NVO
$209B
$2.67M 0.24%
76,950
-16,268
-17% -$542K
AMGN icon
86
Amgen
AMGN
$222B
$2.62M 0.24%
10,301
-398
-4% -$98.6K
VXUS icon
87
Vanguard Total International Stock ETF
VXUS
$163B
$2.57M 0.23%
49,293
+710
+1% +$37.2K
CL icon
88
Colgate-Palmolive
CL
$74.4B
$2.57M 0.23%
33,311
-300
-0.9% -$22.9K
PM icon
89
Philip Morris
PM
$295B
$2.55M 0.23%
33,993
-5,072
-13% -$391K
QCOM icon
90
Qualcomm
QCOM
$176B
$2.53M 0.23%
21,490
– –
TGT icon
91
Target
TGT
$68B
$2.53M 0.23%
16,045
– –
BMY icon
92
Bristol-Myers Squibb
BMY
$132B
$2.5M 0.23%
41,459
-645
-2% -$38.8K
COST icon
93
Costco
COST
$420B
$2.49M 0.23%
7,015
+720
+11% +$242K
MIDD icon
94
Middleby
MIDD
$6.08B
$2.39M 0.22%
26,667
-29,240
-52% -$2.65M
GILD icon
95
Gilead Sciences
GILD
$165B
$2.37M 0.21%
37,460
-1,145
-3% -$79.4K
ITW icon
96
Illinois Tool Works
ITW
$84.5B
$2.34M 0.21%
12,122
-380
-3% -$72.2K
THO icon
97
Thor Industries
THO
$4.14B
$2.23M 0.2%
23,360
-9,464
-29% -$980K
WY icon
98
Weyerhaeuser
WY
$18.4B
$2.1M 0.19%
73,798
-5,962
-7% -$164K
SSNC icon
99
SS&C Technologies
SSNC
$18.6B
$2.1M 0.19%
34,688
-9,482
-21% -$567K
IJH icon
100
iShares Core S&P Mid-Cap ETF
IJH
$127B
$2.09M 0.19%
56,410
+650
+1% +$24.3K
2 3
4
5 6

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return

Boston Family Office's Q3 2020 Portfolio in Review

As of Q3 2020, Boston Family Office held 248 positions worth $1.1B, up 7.1% from $1.03B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Boston Family Office's Q3 2020 filing shows 4 new, 56 increased, 116 reduced and 11 closed positions. Its largest new stake was Relay Therapeutics: 21,121 shares worth $900K. The largest sale was Apple, an estimated $4.51M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Boston Family Office's largest Q3 2020 buy was Relay Therapeutics: 21,121 shares worth $900K.
  • Boston Family Office added most to Zebra Technologies in Q3 2020, an estimated $2.39M increase.
  • Boston Family Office's biggest Q3 2020 reduction was Apple, cutting an estimated $4.51M.
  • Boston Family Office fully exited ICU Medical in Q3 2020, selling an estimated $829K.
  • Boston Family Office's ten largest holdings make up 29% of its $1.1B portfolio in Q3 2020.
  • Boston Family Office opened 4 new positions and closed 11 in Q3 2020.
  • Boston Family Office's portfolio value rose 7.1% quarter-over-quarter to $1.1B.

Based on Boston Family Office's 13F filing for Q3 2020, filed 10 Nov 2020.